Cargando…

Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis

BACKGROUND: India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India’s pharmaceutical industry is the third largest, by volume, globally, but access to CVD drugs i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Newman, Charles, Ajay, Vamadevan S., Srinivas, Ravi, Bhalla, Sandeep, Prabhakaran, Dorairaj, Banerjee, Amitava
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852445/ https://www.ncbi.nlm.nih.gov/pubmed/27141309 http://dx.doi.org/10.1186/s40545-016-0065-7

Ejemplares similares

Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis
por: McMullan, Patrick, et al.
Publicado: (2018)

Coronary heart disease in Indians: Implications of the INTERHEART study
por: Ajay, Vamadevan S., et al.
Publicado: (2010)

"Heart Failure: Meeting the Challenges of Surveillance and Knowledge Translation in Resource-poor Settings"
por: Safraj, Shahulhameed, et al.
Publicado: (2013)

India and the United Kingdom—What big data health research can do for a country
por: Bandopadhyay, Souvik, et al.
Publicado: (2018)

Development of a Smartphone‐Enabled Hypertension and Diabetes Mellitus Management Package to Facilitate Evidence‐Based Care Delivery in Primary Healthcare Facilities in India: The mPower Heart Project
por: Ajay, Vamadevan S., et al.
Publicado: (2016)

m-Power Heart Project - a nurse care coordinator led, mHealth enabled intervention to improve the management of hypertension in India: study protocol for a cluster randomized trial
por: Srinivasapura Venkateshmurthy, Nikhil, et al.
Publicado: (2018)

Association between socioeconomic position and cardiovascular disease risk factors in rural north India: The Solan Surveillance Study
por: Agarwal, Anubha, et al.
Publicado: (2019)

Adherence to diabetes care processes at general practices in the National Capital Region-Delhi, India
por: Shivashankar, Roopa, et al.
Publicado: (2016)

Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
por: Gupta, Priti, et al.
Publicado: (2019)

Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders
por: Erchick, Daniel J., et al.
Publicado: (2022)

A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale
por: Ajay, Vamadevan S, et al.
Publicado: (2014)

Global Cardiovascular Research Output, Citations, and Collaborations: A Time-Trend, Bibliometric Analysis (1999–2008)
por: Huffman, Mark D., et al.
Publicado: (2013)

Pre-hospital acute coronary syndrome care in Kerala, India: A qualitative analysis
por: Patel, Amisha, et al.
Publicado: (2017)

Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study
por: Mishra, Pallavi, et al.
Publicado: (2021)

Disparities in Cardiovascular Research Output and Citations From 52 African Countries: A Time‐Trend, Bibliometric Analysis (1999–2008)
por: Bloomfield, Gerald S., et al.
Publicado: (2015)

Cardiovascular disease in India: Lessons learnt & challenges ahead
por: Prabhakaran, Dorairaj, et al.
Publicado: (2010)

Process evaluation protocol for a cluster randomised trial of a complex, nurse-led intervention to improve hypertension management in India
por: Srinivasapura Venkateshmurthy, Nikhil, et al.
Publicado: (2019)

Deconstructing and Historicizing Access to Medicines: The Changing Priority of Pharmaceutical Governance in China
por: Li, Lantian
Publicado: (2021)

French Government official visits CERN
por: CERN Press Office. Geneva
Publicado: (1963)

Government innovation subsidy, executives’ academic capital and innovation quality: Evidence from pharmaceutical companies in China
por: Xia, Yuntian, et al.
Publicado: (2023)

World Hypertension Day: Contemporary issues faced in India
por: Jose, Arun Pulikkottil, et al.
Publicado: (2019)

Premature coronary heart disease risk factors & reducing the CHD burden in India
por: Prabhakaran, Dorairaj, et al.
Publicado: (2011)

Developing cardiovascular disease risk programs in India—Why location and wealth matter
por: Peiris, David, et al.
Publicado: (2018)

Facilitators and barriers of heart failure care in Kerala, India: A qualitative analysis of health-care providers and administrators
por: Agarwal, Anubha, et al.
Publicado: (2019)

Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in India
por: Jha, Dilip, et al.
Publicado: (2017)

Healthcare providers’ perspective of COVID-19 pandemic on cancer treatment, screening & early detection services in India
por: Kaushik, Aprajita, et al.
Publicado: (2022)

Institutional governance and responsiveness to antimicrobial resistance: a qualitative study of Australian hospital executives
por: Broom, Jennifer, et al.
Publicado: (2021)

Stakeholders’ perceptions regarding a salt reduction strategy for India: Findings from qualitative research
por: Gupta, Priti, et al.
Publicado: (2018)

The Official Indigenous Drugs of India
Publicado: (1902)

A partnership model for capacity-building of primary care physicians in evidence-based management of diabetic retinopathy in India
por: Bhalla, Sandeep, et al.
Publicado: (2020)

What are the Evidence Based Public Health Interventions for Prevention and Control of NCDs in Relation to India?
por: Singh, Kavita, et al.
Publicado: (2011)

Healthcare utilisation and expenditure patterns for cardio-metabolic diseases in South Asian cities: the CARRS Study
por: Gupta, Priti, et al.
Publicado: (2020)

Multimorbidity or multiple long-term conditions: need for bridging the evidence & care gaps to address an emerging priority public health issue in India
por: Gupta, Priti, et al.
Publicado: (2022)

Pre-hospital ECG for acute coronary syndrome in urban India: A cost-effectiveness analysis
por: Schulman-Marcus, Joshua, et al.
Publicado: (2010)

Development of mWellcare: an mHealth intervention for integrated management of hypertension and diabetes in low-resource settings
por: Jindal, Devraj, et al.
Publicado: (2018)

The shaping of pharmaceutical governance: the Israeli case
por: Sax, Philip
Publicado: (2014)

Governance of IT: an executive guide to ISO/IEC 38500
por: Holt, A L
Publicado: (2013)

The National Medical Union (Official): Meeting of Executive Committee. Sanatorium Benefit Statistics
Publicado: (1914)

Improving care for hypertension and diabetes in india by addition of clinical decision support system and task shifting in the national NCD program: I-TREC model of care
por: Jindal, Devraj, et al.
Publicado: (2022)

Association between poor oral health and diabetes among Indian adult population: potential for integration with NCDs
por: Rawal, Ishita, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7t83418ig0psd6jdn4v9f1gqm9